Related Experiment Videos
[Study on the characteristics of agglutination reaction of McAb with Leptospira interrogans outer envelope]
Abstract:
Three McAb were produced against an outer envelope preparation from Leptospira, interrogans, serovar Lai by fusion of SP2/0 myeloma cells with immune BALB/c mice spleen cells. The fusion rate was 96% and the antibody positive rate was 50%. One of the hybridomas, E4B11C9, reacted with 13 of the 13 serovars of the Icterohaemorrhagiae serogroup in microscopic agglutination test (MAT) but did not react with the 18 representative serovars of L. interrogans and L. biflexa serovar patoc and Leptonema illini. For all non-reactive serovars the MAT titres were greater than 1:25. The McAb, E4B7G5, reacted similarly with all serovars except smithi and tonkini. E4B7D4 reacted also similarly with all serovars except serovars birkini, ndambari, bogvere, smithi and tonkini. Therefore, 3 McAb showed serogroup specificity and partial serogroup specificity by agglutination. The agglutination titres were high and hybridomas were stable, so it might be useful in providing a simple, rapid method for the classification and identification of clinical isolates such as pathogenic L. interrogans in place of the complicated and time-consuming conventional methods.
Insights
Monoclonal antibodies (McAb) were developed for Leptospira interrogans serovar Lai. These antibodies demonstrate high specificity, offering a rapid method for identifying pathogenic Leptospira clinical isolates.
Area of Science:
- Immunology
- Microbiology
- Bacteriology
Background:
- Leptospira interrogans is a pathogenic bacterium responsible for leptospirosis.
- Accurate and rapid identification of Leptospira serovars is crucial for disease control.
- Current identification methods are often complex and time-consuming.
Purpose of the Study:
- To produce and characterize monoclonal antibodies (McAb) against Leptospira interrogans serovar Lai.
- To evaluate the specificity of these McAb for classifying Leptospira serovars.
- To assess the potential of McAb for rapid identification of clinical isolates.
Main Methods:
- Production of McAb using hybridoma technology by fusing SP2/0 myeloma cells with immune BALB/c mice spleen cells.
- Screening of McAb using microscopic agglutination test (MAT) against various Leptospira serovars.
- Assessment of antibody reactivity and specificity across different serogroups.
Main Results:
- Three McAb (E4B11C9, E4B7G5, E4B7D4) were successfully produced with high fusion and antibody positive rates.
- McAb E4B11C9 exhibited high specificity, reacting only with the Icterohaemorrhagiae serogroup.
- Other McAb demonstrated partial serogroup specificity, differentiating between specific serovars.
Conclusions:
- The developed McAb possess significant serogroup and partial serogroup specificity.
- High agglutination titers and stable hybridomas suggest utility in diagnostics.
- These McAb offer a promising simple, rapid alternative for classifying and identifying pathogenic Leptospira clinical isolates.